Search

Displaying results 3641 - 3650 of 7897 in total
  1. Drug

    DNB-001

    go.drugbank.com/drugs/DB05757
    Investigational

    In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve. … DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma.

  2. Drug

    DG041

    go.drugbank.com/drugs/DB05027
    Experimental

    DG041, an anti-platelet compound, has shown to be a selective and potent antagonist of the EP3 receptor for prostaglandins E2. … EP3 is a target that associates with increased risk of various vascular diseases.

  3. Drug

    NKX101

    go.drugbank.com/drugs/DB18131
    Investigational

    NKX101 is an investigational allogeneic chimeric antigen receptor (CAR)-natural killer cell therapy.

    Synonyms: a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15
  4. Drug

    rAAV1-CB-hAAT

    go.drugbank.com/drugs/DB18724
    Investigational

    rAAV1-CB-hAAT is a recombinant adeno-associated virus alpha 1-antitrypsin vector.

    Synonyms: rAAV1-CB-hAAT
  5. Drug

    ABG-023

    go.drugbank.com/drugs/DB18829
    Experimental

    ABG-023 is a glucagon analog which is soluble and solution-stable.[L50778]

  6. Drug

    NS-3728

    go.drugbank.com/drugs/DB05835
    Experimental

    NS3728 is an orally active chloride channel blocker for the treatment of cancer.

  7. Drug

    Norethindrone enanthate

    go.drugbank.com/drugs/DB14678
    Investigational

    Mixtures: AI PROFAMILIA
  8. Drug

    AP-101

    go.drugbank.com/drugs/DB17947
    Investigational

    AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.

  9. Drug

    Satricabtagene autoleucel

    go.drugbank.com/drugs/DB18288
    Investigational

    Satricabtagene autoleucel is an autologous CAR T-cell product candidate against protein Claudin18.2 (CLDN18.2).

  10. Drug

    Audencel

    go.drugbank.com/drugs/DB18386
    Investigational

    AV-0113 consists of IL-12 secreting dendritic cells loaded with autologous tumor lysate.